eFoodSafety Announces: Cinnergen(TM) to be Available in Drugstore Outlets.

SCOTTSDALE, Ariz. -- eFoodSafety.com, Inc. (OTCBB:EFSF), announced today that the company has reached an agreement to supply eFoodSafety's Cinnergen to 3,000 Rite Aid Drugstores by mid-September.

Cinnergen[TM]is a clinically proven all-natural supplement for promoting healthy glucose metabolism. A recently publicized study from Bucks County Clinical Research, an FDA-approved and regulated research facility, showed that 52% of Type 2 diabetic patients in the study were able to control their blood sugars with Cinnergen[TM] alone and did not experience any irregular sugar spikes throughout the day. The remaining 48 percent of patients taking Cinnergen[TM] were able to significantly decrease the amount of prescribed diabetic medications in order to properly control their diabetes.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc., is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd., subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax, and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 - that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc., subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn[TM]-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn[TM] line. The Company is also owner of Cinnergen[TM], a clinically studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Cinnechol[TM], a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc., to launch the PurEffect[TM] anti-acne skin care system.

Please visit the Company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.